[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100585085":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":15,"locations":22,"responsibleParty":41,"collaborators":10,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":45,"sex":50,"minAge":51,"maxAge":52,"enrollmentInfo":53,"targetDuration":10,"studyType":56,"phases":10,"briefSummary":57,"conditions":58,"keywords":10,"overallStatus":25,"whyStopped":10,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":69},{"fullName":5,"class":6},"Bakirkoy Dr. Sadi Konuk Research and Training Hospital","OTHER_GOV",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Early Group",null,"The group in which transcutaneous electrical nerve stimulation will be inserted immediately after intubation",{"label":13,"type":10,"description":14,"interventionNames":10},"Late Group","The group to be fitted with transcutaneous electrical nerve stimulation 48 hours after intubation",[16],{"name":17,"role":18,"phone":19,"phoneExt":20,"email":21},"Safiye Tuba Kaplan","CONTACT","+9","05325690108","sipahituba79@gmail.com",[23],{"facility":24,"status":25,"city":26,"state":27,"zip":10,"country":28,"countryCode":10,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"Dr.SadiKonuk EAH","RECRUITING","Istanbul","Bakirkoy","Turkey (Türkiye)",{"type":30,"coordinates":31},"Point",[32,33],28.94966,41.01384,{"lat":33,"lon":32},[36,39],{"name":37,"role":18,"phone":19,"phoneExt":38,"email":10},"DrSadiKonuk DrSadiKonuk","0212 3777138",{"name":17,"role":40,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"type":40,"investigatorFullName":17,"investigatorTitle":42,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Doctor","100585085","does-transcutaneous-phrenic-nerve-stimulation-prevent-diaphragm-atrophy-100585085",false,"NCT06897774","Does Transcutaneous Phrenic Nerve Stimulation Prevent Diaphragm Atrophy?","NMES","Inclusion Criteria:Patients on invasive mechanical ventilation for 72 hours or more Patients older than 18 years\n\nExclusion Criteria: Patients under 18 years of age\n\n* Patients with less than 72 hours of mechanical ventilation\n* Pregnancy\n* Patients with a body mass index above 35kg\u002Fm²\n* Neuromuscular disease\n* Refractory epilepsy\n* Patients with pacemakers\n* ARDS\n* Unilateral or bilateral diaphragm paralysis\n* Presence of pneumothorax\n* Patients with large right pleural effusion\n* Tracheostomized patients\n* Patients undergoing upper abdominal surgery","ALL","18 Years","80 Years",{"count":54,"type":55},80,"ESTIMATED","OBSERVATIONAL","Dear participant Participants's patient, who is participants's first-degree relative, who is connected to a ventilator in the intensive care unit, unconscious and not authorized to give informed consent, has been invited to participate in the study titled 'Does transcutaneous phrenic nerve stimulation prevent diaphragm atrophy?\n\nIn order to strengthen this muscle and prevent loss of function, investigator provide electrical stimulation between the rib cage and abdomen through the skin with the tens device, causing the muscle to contract and enabling our patient to leave the respirator early.\n\nInvestigator aimed to investigate the protective effect of the tens device on the diaphragm by evaluating the diaphragm muscle with the ultrasonography device during the period when it is connected to the respirator. For this reason, the diaphragm will be contracted by giving electrical stimulation three times a day for 30 minutes with the tens device for 5 days during the period when participants's patient is connected to the respirator, and intermittent diaphragm ultrasound will be evaluated.\n\nParticipants or participants's legal guardian are asked to approve the use of participants's medical records during participants's treatment in the intensive care unit, provided that participants's personal information is kept confidential. Participants will not incur any financial burden by participating in the study and participants will not receive any additional payment.\n\nParticipants are free to leave the study at any time if deemed necessary, and the researcher can terminate the study if deemed necessary. The information obtained within the scope of the research can be used for scientific purposes and can be presented and published provided that the confidentiality record is respected.\n\nI have read (or orally listened to) the text above, which contains the information given to the participants before the research began. I agree to participate in the study as a Volunteer. I consent to the use of my medical information. I also understand that if I do not agree to participate in the study, my treatment will be carried out in full without interruption.\n\nParticipant name and surname:\n\nParticipant's relative's name and surname:\n\nDegree of closeness:\n\nSignature \u002F Date:",[59],"Critical Care, Intensive Care","2025-03-26",{"date":62,"type":63},"2025-03-27","ACTUAL",{"date":65,"type":63},"2024-01-22",{"date":67,"type":55},"2025-04-22",{"name":5,"class":6},1]